Comment on 'Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer'-No support for de-escalation of immunotherapy

被引：1

作者：

Georgiou, Alexandros ^{[1
]}

Minchom, Anna ^{[1
]}

O'Brien, Mary ^{[1
]}

机构：

[1] Royal Marsden Hosp Fdn Trust, London, England

来源：

EUROPEAN JOURNAL OF CANCER | 2019年 / 115卷

关键词：

DOCETAXEL; NIVOLUMAB; ATEZOLIZUMAB;

D O I：

10.1016/j.ejca.2019.04.011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：24 / 26

页数：3

共 50 条

[1] Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer [J].

Levy, Benjamin P. ;

Giaccone, Giuseppe ;

Besse, Benjamin ;

Felip, Enriqueta ;

Garassino, Marina Chiara ;

Domine Gomez, Manuel ;

Garrido, Pilar ;

Piperdi, Bilal ;

Ponce-Aix, Santiago ;

Menezes, Daniel ;

MacBeth, Kyle J. ;

Risueno, Alberto ;

Slepetis, Ruta ;

Wu, Xiaoling ;

Fandi, Abderrahim ;

Paz-Ares, Luis .

EUROPEAN JOURNAL OF CANCER, 2019, 108 :120-128

[2] Pembrolizumab plus allogeneic NK cells in advanced non-small cell lung cancer patients [J].

Lin, Mao ;

Luo, Haihua ;

Liang, Shuzhen ;

Chen, Jibing ;

Liu, Aihua ;

Niu, Lizhi ;

Jiang, Yong .

JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (05) :2560-2569

[3] Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer The PROLUNG Phase 2 Randomized Clinical Trial [J].

Arrieta, Oscar ;

Barron, Feliciano ;

Ramirez-Tirado, Laura Alejandra ;

Zatarain-Barron, Zyanya Lucia ;

Cardona, Andres F. ;

Diaz-Garcia, Diego ;

Yamamoto Ramos, Masao ;

Mota-Vega, Beatriz ;

Carmona, Amir ;

Peralta alvarez, Marco Polo ;

Bautista, Yolanda ;

Aldaco, Fernando ;

Gerson, Raquel ;

Rolfo, Christian ;

Rosell, Rafael .

JAMA ONCOLOGY, 2020, 6 (06) :856-864

[4] Pembrolizumab Plus Docetaxel Increases Progression-Free Survival Compared with Docetaxel Alone in Previously Treated Advanced Non-Small Cell Lung Cancer Patients [J].

Arrieta, O. G. ;

Barron, F. ;

Carmona, A. ;

Ramirez-Tirado, L. ;

Zatarain Barron, Z. L. ;

Cardona, A. F. ;

Bautista, Y. ;

Aldaco, F. ;

Lazaro, M. ;

Baez, R. ;

Gerson, R. ;

Blanco, C. .

JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) :S291-S291

[5] Retreatment with pembrolizumab in advanced non-small cell lung cancer patients previously treated with nivolumab: emerging reports of 12 cases [J].

Fujita, Kohei ;

Uchida, Naohiro ;

Kanai, Osamu ;

Okamura, Misato ;

Nakatani, Koichi ;

Mio, Tadashi .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (06) :1105-1109

[6] Combination pembrolizumab plus chemotherapy: a new standard of care for patients with advanced non-small-cell lung cancer [J].

Weinberg, Frank ;

Gadgeel, Shirish .

LUNG CANCER-TARGETS AND THERAPY, 2019, 10 :47-56

[7] Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non-Small-Cell Lung Cancer Previously Treated With Immunotherapy-Lung-MAP S1800A [J].

Reckamp, Karen L. ;

Redman, Mary W. ;

Dragnev, Konstantin H. ;

Minichiello, Katherine ;

Villaruz, Liza C. ;

Faller, Bryan ;

Al Baghdadi, Tareq ;

Hines, Susan ;

Everhart, Leah ;

Highleyman, Louise ;

Papadimitrakopoulou, Vassiliki ;

Gandara, David R. ;

Kelly, Karen ;

Herbst, Roy S. .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (21) :2295-+

[8] Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non-small-cell lung cancer: A multicenter retrospective trial [J].

Matsumoto, Hiromi ;

Kobayashi, Nobuaki ;

Somekawa, Kohei ;

Fukuda, Nobuhiko ;

Kaneko, Ayami ;

Kamimaki, Chisato ;

Kubo, Sousuke ;

Tanaka, Katsushi ;

Tagami, Yoichi ;

Teranishi, Shuhei ;

Watanabe, Keisuke ;

Horita, Nobuyuki ;

Hara, Yu ;

Yamamoto, Masaki ;

Kudo, Makoto ;

Koizumi, Harumi ;

Miura, Kenji ;

Miyazawa, Naoki ;

Kaneko, Takeshi .

THORACIC CANCER, 2022, 13 (02) :228-235

[9] Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab [J].

Jo, Hitomi ;

Yoshida, Tatsuya ;

Horinouchi, Hidehito ;

Yagishita, Shigehiro ;

Matsumoto, Yuji ;

Shinno, Yuki ;

Okuma, Yusuke ;

Goto, Yasushi ;

Yamamoto, Noboru ;

Takahashi, Kazuhisa ;

Motoi, Noriko ;

Ohe, Yuichiro .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (02) :387-398

[10] Nivolumab versus pembrolizumab in previously-treated advanced non-small cell lung cancer patients: A propensity-matched real-world analysis [J].

Torasawa, Masahiro ;

Yoshida, Tatsuya ;

Yagishita, Shigehiro ;

Shimoda, Yukiko ;

Shirasawa, Masayuki ;

Matsumoto, Yuji ;

Masuda, Ken ;